It is highly expressed in patients with liver cancer and is significantly related to poor prognosis, and mediates liver cancer and apoptosis by regulating LGR5-mediated β-catenin and c-Myc signaling (Koo et al., 2019). The gene discussed is MYC; the disease is liver cancer.